In this study, we evaluate TOLLIP expression, investigate its correlations with clinicopathological features of renal cell carcinoma, and explore its potential use as a prognostic marker and the target point for targeted immunotherapy in RCC. Here, TOLLIP is linked to renal cell carcinoma.